Delivery Order SPE2DR25D2005-SPE2DR26FE6B4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injections with a contract ceiling value of $16,963.63. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $4,564.98. This firm fixed-price delivery order, with an ultimate completion date of October 28, 2025, represents a small-value pharmaceutical transaction supporting federal medical procurement needs. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,628.68 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injections, valued at $1,181.90, with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $1,453.70 under a firm fixed-price contract. The order, which is scheduled for completion by October 24, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, non-set-aside delivery order represents a single transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $3,883.38. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 16,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $7,798.34 with a completion date of August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's broader pharmaceutical supply contract portfolio. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6B4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $2,372.39. This is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and represents a non-set-aside competitive award. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contract portfolio predominantly with the Defense Logistics Agency's Medical Supply Chain. As a prime contractor under the DLA's pharmaceutical procurement framework, the company supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The firm fixed-price structure and competitive award process reflect AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition, consistent with its extensive track record of delivering diverse pharmaceutical products across multiple therapeutic domains to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/3/25 |